Valuation MannKind Corporation

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-27 EDT			5-day change	1st Jan Change
3.950 ^USD	-4.36%		-0.75%	-30.34%

07-24	MannKind's Furoscix Auto-Injector Approval, Launch Could Provide Strong Upside to 2026 Revenue Expectation, Wedbush Says	MT
07-24	MannKind Corporation announced that it expects to receive $49.999998 million in funding from Frazier Life Sciences Management, LP	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,098	1,387	981.3	1,773	1,741	1,220	-	-
Change	-	26.33%	-29.26%	80.71%	-1.81%	-29.91%	-	-
Enterprise Value (EV)	1,098	1,387	679	1,773	1,741	1,220	1,220	1,220
Change	-	26.33%	-51.05%	161.16%	-1.81%	-29.91%	0%	0%
P/E	-13.7x	-15.5x	-91x	64.3x	284x	-461x	25.9x	24.1x
PBR	-	-	-	-	-	-	-	-
PEG	-	-2.48x	1x	-0x	-3.6x	3x	-0x	3.27x
Capitalization / Revenue	14.6x	13.9x	4.93x	6.21x	4.99x	2.64x	2.34x	2.27x
EV / Revenue	0x	0x	0x	0x	0x	2.64x	2.34x	2.27x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	0x	0x	0x	20.6x	13.1x	11.7x
EV / FCF	-	-	-0x	0x	0x	61x	17.9x	55.5x
FCF Yield	-	-	-0.85%	1.85%	0.79%	1.64%	5.57%	1.8%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.32	-0.34	-0.04	0.1	0.02	-0.00857	0.1525	0.1638
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	75.44	99.77	199	285.5	349	462.5	522.3	536.7
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-47.02	-64.11	8.678	72.59	38.8	59.29	92.95	104.1
Net income ¹	-80.93	-87.4	-11.94	27.59	5.863	4.029	55.71	69.44
Net Debt	-	-	-302.3	-	-	-	-	-
Reference price ²	4.370	5.270	3.640	6.430	5.670	3.950	3.950	3.950
Nbr of stocks (in thousands)	251,256	263,196	269,575	275,778	307,070	308,950	-	-
Announcement Date	2/24/22	2/23/23	2/27/24	2/26/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MANNKIND CORPORATION	-460.91x	-	-	-	1.22B
ARGENX SE	33.11x	8.21x	25.31x	0.04%	56.19B
WUXI APPTEC CO., LTD.	20.62x	6.35x	13.89x	1.54%	54.83B
INSMED INCORPORATED	-41x	13.02x	-38.35x	-.--%	22.7B
BIONTECH SE	-18.25x	4.33x	-7.59x	-.--%	23.04B
WUXI BIOLOGICS (CAYMAN) INC.	25.46x	4.98x	13.19x	-.--%	20.23B
GENMAB A/S	24.92x	4.83x	15.71x	-.--%	17.83B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-786.44x	37.38x	-4208.26x	-.--%	15.65B
PHARMAESSENTIA CORPORATION	45.88x	18.59x	47.88x	0.08%	15.24B
EXELIXIS, INC.	17.56x	5.09x	11.87x	-.--%	14.03B
Average	-113.90x	11.42x	-458.48x	0.19%	24.1B
Weighted average by Cap.	-38.71x	9.73x	-263.99x	0.37%